Cameco Corp. (CCJ) Misses Q3 EPS by 5c, Sales Fall Short
Tweet
Share
E-mailGet Alerts CCJ Hot Sheet
Join SI Premium – FREE
Cameco Corp. (NYSE: CCJ) reported Q3 adjusted EPS of $0.26, $0.05 worse than the analyst estimate of $0.31. Revenue for the quarter came in at $527 million versus the consensus estimate of $593.53 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cameco Corporation (CCJ) PT Raised to $130 at Truist Securities
- Reading (RDI) Tops Q2 EPS by 4c
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
